Medrx Co. Ltd. reported consolidated earnings results for the nine months ended September 30, 2017. For the nine months, the company reported consolidated net sales of JPY 19 million, operating loss of JPY 813 million, ordinary loss of JPY 817 million, net loss of JPY 712 million or JPY 83.65 per share, compared to net sales of JPY 22 million, operating loss of JPY 1,050 million, ordinary loss of JPY 1,019 million, net loss of JPY 996 million or JPY 125.22 per share, a year ago.

The company provided consolidated earnings guidance for the full year ending December 31, 2017. For the full year, the company is forecasting its net sales of JPY 186 million, operating loss of JPY 1,261 million, ordinary loss of JPY 1,244 million, net loss of JPY 1,206 million or JPY 141.70 per share.